- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01693796
Evaluation of Thyroid Exposure to Radiation Doses During Paediatric Cardiac Catheterisations Performed for Diagnosis or the Treatment of Congenital Heart Disease
July 27, 2023 updated by: Assistance Publique Hopitaux De Marseille
The purpose of this study is to determine the average risk for thyroid irradiation for any type of paediatric cardiac catheterization, based on the cummulative at-risk dose of 100 mSv, adjusted to the measured thyroid volume and to the patient's age.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
52
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Marseille, France, 13354
- Assistance Publique Hopitaux de Marseille
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
No older than 18 years (Child, Adult)
Accepts Healthy Volunteers
No
Description
Inclusion Criteria:
- Inclusion of any patient (< 18 year-old) with congenital heart disease undergoing one or more cardiac catheterization
Exclusion Criteria:
- Exclusion of patients with any type of thyroid dissease
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
exposure to radiation measure
Time Frame: 2 YEARS
|
To determine the average risk for thyroid irradiation for any type of paediatric cardiac catheterization, based on the cummulative at-risk dose of 100 mSv, adjusted to the measured thyroid volume and to the patient's age.
|
2 YEARS
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
exposure to radiation measure
Time Frame: 2 YEARS
|
Fit the dose of average irradiation of the thyroid during the catheterizations to the thyroïdien volume
|
2 YEARS
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Investigators
- Study Chair: BERNARD BELAIGUES, Assistance Publique Hopitaux de Marseille
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
March 1, 2011
Primary Completion (Actual)
April 1, 2015
Study Completion (Actual)
April 1, 2015
Study Registration Dates
First Submitted
April 5, 2011
First Submitted That Met QC Criteria
September 24, 2012
First Posted (Estimated)
September 26, 2012
Study Record Updates
Last Update Posted (Actual)
July 28, 2023
Last Update Submitted That Met QC Criteria
July 27, 2023
Last Verified
August 1, 2015
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 2010-A01118-31
- 2010-09 (Other Identifier: AP HM)
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Cardiac Catheterizations
-
Ostfold University CollegeNot yet recruitingCardiac Arrest | Cardiac Arrhythmia | Cardiac Disease | Cardiac Death
-
Groupe Hospitalier Paris Saint JosephWithdrawnCardiac Ultrasound | Cardiac Echography
-
Shanghai Zhongshan HospitalRecruitingCardiac Surgery | Cardiac OutputChina
-
Massachusetts General HospitalWithdrawnCardiac Physiology | Cardiac OutputUnited States
-
Ramsay Générale de SantéEuropean Clinical Trial Experts NetworkRecruitingCardiac MRI | Right Cardiac CatheterizationFrance
-
Medtronic Cardiac Rhythm and Heart FailureTerminatedCardiac Pacemaker, Artificial | Cardiac Pacing, ArtificialCanada, United States, Israel, Italy, Qatar, China
-
Zoll Medical CorporationCompletedSudden Cardiac Death | Cardiac Event | Cardiac Arrythmias | Left Ventricular DysfunctionFrance
-
Maastricht University Medical CenterZonMw: The Netherlands Organisation for Health Research and Development; Getinge...CompletedCardiac Arrest | Sudden Cardiac Death | Out-Of-Hospital Cardiac ArrestNetherlands
-
Johns Hopkins UniversityTerminatedCardiac Valve Replacement | Cardiac Surgery-CABGUnited States
-
Idoven 1903 S.L.Spanish Society of Cardiology; Fundación de Investigación en Red en Enfermedades...RecruitingCardiomyopathies | Cardiac Arrest | Sudden Cardiac Death | Cardiac ArrhythmiasSpain
Clinical Trials on blood and urine samples ; Echography
-
Institut National de la Santé Et de la Recherche...Completed
-
Central Hospital, Nancy, FranceCompletedMyocardial InfarctionFrance
-
Hospices Civils de LyonUnknownWilliams-Beuren Syndrome | Micro-duplication 7q11.23 Syndrome | VasculopathyFrance
-
Institut BergoniéUnknown
-
Centre Georges Francois LeclercCompleted
-
Nantes University HospitalCompletedNeonatal Acute Renal Failure in PretermFrance
-
Assistance Publique - Hôpitaux de ParisCompletedCongenital Heart Defects | Chronic Kidney FailureFrance
-
Centre Hospitalier Universitaire, AmiensInstitut Pasteur de Lille; Université de LilleRecruitingNephrolithiasis | Kidney StoneFrance
-
University Hospital, LimogesUniversity Hospital Federation FHU SUPORTRecruiting
-
Herlev HospitalCompletedChronic Kidney Diseases | Mineral Metabolism DisorderDenmark